Dais Newsfeed | 06/08/2021 03:50 PM | Click to read full article
Global healthcare major Johnson & Johnson on Friday said it has applied for Emergency Use Authorization of its single-dose COVID-19 vaccine in India. Earlier on Monday, the company had said that it remained committed to bringing its single-dose COVID-19 vaccine to India and looks forward to ongoing discussions with the Indian government.
“On August 5, 2021 Johnson & Johnson Pvt Ltd applied for EUA of its single-dose COVID-19 vaccine to the government of India,” a Johnson & Johnson India spokesperson said in a statement. This is an important milestone that paves the way for bringing the company’s single-dose COVID-19 vaccine to the people of India, and the rest of the world, through a collaboration with Biological E Limited, the statement added.